was estimated

The worldwide market for insulin pumps to 6.4 million in 2009 and is expected to reach 051m in 2016 after growing at a compound annual growth rate (CAGR) of 9% from 2009 to 2016. Market growth is mainly due to growing population and obesity, technological developments (the emergence of an artificial pancreas and a system of distribution of insulin and glucagon) and rising driven by patient awareness. provided through the advantages of flexibility and control of glucose by insulin pumps for niche patient populations such as pregnant women and children, is the market for insulin pumps has grown rapidly in recent years.

Insulin Pumps U.S. market in 2016 reached 3m, growing at an annual rate of 9% from 2009 to 2016. Insulin the traditional market was valued at $ 4,000,000 in 2009 and disposable insulin pump segment at 0.9 m in 2009 was estimated. The United States remains the largest market for insulin pumps. The market for insulin pumps in the United States will be driven by increasing penetration of established players and new-generation pumps such as artificial pancreas and the co-administration of insulin and glucagon.

For more details, please type or paste the link below into your browser:

http://www.globaldata.com/reportstore/Report.aspx?ID = insulin-pump-pipeline-Global Analysis-Opportunity Assessment and Market Forecasts to 2016 = & report-type Industry_Report & core industry

= ALL & title = Medical_Devices

Diabetes caused nearly four million deaths per year. The International Diabetes Federation (IDF) estimates that globally, by 2025 almost 380 million people have diabetes. The diabetic population is expected to be settled in developing countries because of the people leading longer lives, to grow dietary changes and urbanization. Seven of the ten countries with the largest number of people with diabetes in developing countries. China, India and the United States comprise the majority of the diabetic population. The rate of obesity has increased worldwide in recent decades. Currently, more than a billion adults worldwide are overweight, which is an important risk factor for diabetes. This increases the prevalence of diabetes and should lead the market for insulin pumps.

The leader of the Medtronic insulin pumps market is 58% of the market in 2009. Medtronic MiniMed Paradigm sells well on insulin pumps on the market as it was the first insulin pump in real-time continuous glucose monitoring companies to integrate (DMC) system and provides tighter control of glucose and improving the quality of life. Roche is the second largest company in the insulin pump in the market with a market share of 12%. Insulin pump from Roche accucheck spirit strong growth of insulin pumps in the market with features such as three operating menus, four bolus options and five profiles of base flow and small experienced. MiniMed (Medtronic) and Disetronic Medical Systems (Roche) were important players in the segment of insulin pumps to 2000. The market then fragmented with the entry of companies such as Animas Corporation with his insulin pump and Deltec Cozmo insulin pump with R1000.

Report

GlobalData Medical, insulin pumps -. Global pipeline analysis, evaluation of opportunities and forecasts to 2016 “provides important data, information and analysis on insulin pumps global market report market landscape, competitive landscape and market trends provides the information market for insulin pumps. The report contains detailed information on important trends, the market and the most important analytical content to the market dynamics. The report also examines the competitive environment, key pipeline products and technology offerings. This report is distributed by using data and information from proprietary databases, primary and secondary research and analysis internally by the team global data from industry experts

Visit our Shop in the report. www.globaldata.com report gates /

Medtronic Insulin Pump